Schlesinger Michael A. 4

4 · Ortho Clinical Diagnostics Holdings plc · Filed Aug 18, 2021

Form 4

Period: 2021-08-16

EVP, GC and Secretary

Transactions

Exercise/Conversion
Ordinary Shares, $0.00001 par value
2021-08-16$6.28/sh+4,000$25,120→ 91,637 total
Sale
Ordinary Shares, $0.00001 par value
2021-08-18$20.14/sh−41,015$826,013→ 87,637 total
Exercise/Conversion
Stock Option
2021-08-18−41,015→ 293,507 total
Exercise: $6.28Exp: 2024-10-22→ Ordinary Shares, $0.00001 par value (41,015 underlying)
Sale
Ordinary Shares, $0.00001 par value
2021-08-16$20.03/sh−4,000$80,110→ 87,637 total
Exercise/Conversion
Ordinary Shares, $0.00001 par value
2021-08-18$6.28/sh+41,015$257,574→ 128,652 total
Exercise/Conversion
Stock Option
2021-08-16−4,000→ 334,522 total
Exercise: $6.28Exp: 2024-10-22→ Ordinary Shares, $0.00001 par value (4,000 underlying)

Footnotes (5)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
[F2]The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4.
[F3]Represents the weighted average sales price for the price increments ranging from $20.0000 to $20.1500.
[F4]Represents the weighted average sales price for the price increments ranging from $20.0000 to $20.3200.
[F5]The stock option is fully vested and exercisable.

Documents

1 file